Far be it for me to be the voice of reason, but ha
Post# of 148265
I believe there is a concern that empirical safety data does not exist for this leronlimab.
Are there any randomized, double blind, controlled studies of significant size that prove efficacy?
Moreover, is there not a concern that the first FDA letter was prompted by investors and friends of Leronlimab badgering political officials?